$CNVS

Cineverse (CNVS) Q4 2026 Earnings Call Transcript

Cineverse (CNVS) reported Q4 2026 revenue of $26.0 million (+67% y/y), driven by acquisitions including Giant Worldwide and IndiCue. Net income rose to $1.1 million (+51%). FY2026 revenue fell to $65.7 million (-16%) versus a prior-year comparison boosted by Terrifier 3. SVOD subscribers were 1.52 million (+13%). Management guided FY2027 revenue to $115–$120 million and adjusted EBITDA to $10–$20 million.

Original reporting
Published Jun 27, 2026, 2:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 27, 2026, 2:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cineverse (CNVS) Q4 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$CNVSBullishMed
01

Why it matters

The call discloses Q4 performance, acquisition contribution, margin dynamics, liquidity/credit facility details, and—most importantly—FY2027 revenue and adjusted EBITDA guidance plus a quantified $10M annualized cost-reduction plan.

02

Market read

For CNVS, the combination of reiterated FY2027 targets and quantified integration/cost actions provides a concrete basis to reprice growth vs. margin/liquidity risks.

03

What to watch

The transcript flags “temporarily” depressed CPMs/fill rates from FAST inventory competition; traders may focus on whether technology revenue mix (>50%) materializes fast enough to offset margin pressure.

Relevance 7/10Novelty 7/10Timing: ahead of/around the Q4 earnings release and investor digestion of FY2027 guidance

Background

Cineverse is transitioning to an AI-driven, technology-first model after acquisitions of Giant Worldwide and IndiCue, integrating Matchpoint for content ingestion and monetization.

Company-level read

Ticker impact

$CNVSBullishMedium confidence
Context

Cineverse reported Q4 revenue of $26.0M (+67% YoY) and reiterated FY2027 guidance of $115M–$120M revenue and $10M–$20M adjusted EBITDA.

Expected impact

Likely supportive for the stock on guidance credibility, with volatility tied to integration execution and ad-pricing pressure (CPMs/fill rates).

Evidence & confidence

The article provides concrete quarterly metrics plus explicit FY2027 revenue/EBITDA ranges and a $10M annualized savings plan, which are actionable for positioning; however, it’s a transcript/summary and lacks consensus/market reaction data.

Market effects

Highlights a shift toward ad-supported streaming monetization and AI-driven content supply chains, relevant to streaming/CTV advertising tech narratives.

No clear regional-specific impact beyond US-listed small-cap streaming/tech sentiment.

Limited; primarily company-specific guidance for a niche streaming/advertising platform.

Counterpoint

Despite strong subscriber/viewer growth, direct operating margin fell (40% vs 55%) and working capital is negative, so the market may discount guidance until integration costs and ad pricing stabilize.

Key entities

  • Cineverse Corp.

    Reported Q4/FY2026 results and reiterated FY2027 revenue ($115M–$120M) and adjusted EBITDA ($10M–$20M) guidance while detailing integration synergies and cost cuts.

Related articles

$CNVSMed

Cineverse Launches VAUDIO™ to Help Brands Expand Audio Campaigns to CTV

Cineverse (Nasdaq: CNVS) launched VAUDIO™, an ad-tech offering that converts existing audio ads (podcast, radio, or streaming audio) into CTV visuals and deploys them across connected TV inventory without a traditional video shoot. The company expects VAUDIO™ to contribute up to $12 million in annual revenue at a 15% to 20% margin, targeting the run rate by fiscal year end. Launch partners include A24 and others.

$CNVSMed

Cineverse Corp. (CNVS): Results of Operations and Financial Condition

Cineverse Corp. (CNVS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cnvs-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Cineverse Reports Fourth Quarter and Fiscal Year 2026 Results • Transformative acquisitions of IndiCue and Giant Worldwide complete Cineverse’s evolution into an AI-driven, fully integrated entertainment technology company an

$BHSTMed

BioHarvest Sciences Q2 Earnings Call Highlights

BioHarvest Sciences (NASDAQ:BHST) reported Q2 gross profit of $5.1M and a net loss of $3.7M ($0.17/share). Cash was $16.2M at June 30. 2026 revenue guidance was cut to $37M-$40M and EBITDA loss to $3M-$5M. Management tightened CDMO revenue to $4M-$5M and reduced VINIA outlook to $33M-$35M.

$SVCMedAI 8/10

Service Properties Trust (SVC) Q2 2026 Earnings Call Transcript

Service Properties Trust (SVC) reported Q2 2026 normalized FFO per share of $0.43, matching consensus. Retained hotel RevPAR rose 6.6% to $135 and retained hotel EBITDA increased 4.2% to $57 million. The company redeemed $550 million of unsecured debt using proceeds from a $542 million net equity offering and issued 2026 FFO guidance of $124 million to $144 million ($1.20 to $1.35/share).

$LZMedAI 8/10

LegalZoom (LZ) Q2 2026 Earnings Call Transcript

LegalZoom (LZ) reported Q2 2026 revenue of $205.3 million, up 7% year over year, driven by subscription revenue of $133.4 million (+11%). Transaction revenue fell 1% to $71.9 million. Adjusted EBITDA rose 18% to $45.9 million and free cash flow was $33.7 million. Full-year revenue guidance is $795-$805 million and adjusted EBITDA $190-$195 million.

$SNEXMedAI 8/10

StoneX (SNEX) Q3 2026 Earnings Call Transcript

StoneX Group Inc. (SNEX) reported Q3 FY2026 net operating revenues of $719.7 million, up 47% year over year, and net income of $127.9 million, up 102%. Diluted EPS was $1.00, up 85% after a 3-for-2 stock split. Segment results cited growth from R.J. O’Brien and The Benchmark acquisitions, plus a Shinhan Bank partnership.